This study investigates pancreatic adenocarcinoma. Researchers are focusing on understanding the condition by examining its stages and the tumor microenvironment.
This study evaluates the potential of new technologies to analyze tumor cell subtypes and interactions within the microenvironment, with the purpose of improving treatment strategies.
- Who can participate: Adults over 18 with pancreatic adenocarcinoma who are eligible for surgery and chemotherapy can participate. Informed consent is required.
- Study details: Participants will undergo procedures related to pancreatic adenocarcinoma treatment. Some may receive a placebo, an inactive substance that looks like the investigational medicine but does not contain any medicine.